HER Act

HR 3749, the HER Act, directs the U.S. Department of Health and Human Services to fund research on how endocrine-disrupting chemicals (chemicals that interfere with hormones) in personal care products affect women’s reproductive health. It provides federal grants for scientific research and requires states to receive funding for investigating these chemicals and running public awareness campaigns about safer alternatives. Every five years, the Department must publish reports detailing research findings, listing safe/harmful products, and suggesting ways to expand FDA regulation of harmful ingredients. This bill directly affects women’s health researchers, state health agencies, and consumers seeking safer personal care products, while aiming to inform future regulatory action.